{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:36:12Z","timestamp":1780616172529,"version":"3.54.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of the review<\/jats:title>\n            <jats:p>Acute brain injuries are the leading cause of morbidity and disability worldwide. Lately, we have observed significant advances in neuroimaging, which have resulted in improved radiological diagnostics; however, laboratory biomarkers of central nervous system (CNS) injury are still not part of routine workup.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Numerous studies proposed potential acute brain injury biomarker candidates. New data extend the use of well-known CNS-derived proteins and enzymes to acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage patients. The growing interest in microRNA (miRNA) profiling brings encouraging results for its possible utility as a biomarker of CNS injury in clinical practice. New data are also reported in the area of inflammatory markers \u2013 both well-studied and new proposed agents, such as growth differentiation factor 15, demonstrate promising perspectives to be used in prognostication following traumatic brain injury. More researchers propose combined biomarker test panels including proteins, miRNA, and inflammatory parameters, to increase the sensitivity and specificity of assessments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>This review aimed to present recent findings on acute brain injury biomarkers that could be implemented in the management of neurocritical patients. Researchers report data on new potential CNS injury biomarker candidates that must still be validated and standardized in large randomized trials.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aco.0000000000001532","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T15:00:09Z","timestamp":1749567609000},"page":"584-590","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Biomarkers of acute brain injury"],"prefix":"10.1097","volume":"38","author":[{"given":"Katarzyna","family":"Prus","sequence":"first","affiliation":[{"name":"Department of Neurology, Stroke and Early Poststroke Rehabilitation, University Clinical Hospital No. 4, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Seku\u0142a","sequence":"additional","affiliation":[{"name":"Department of Neurology, Stroke and Early Poststroke Rehabilitation, University Clinical Hospital No. 4, Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bilotta","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Management, Sapienza University of Rome, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,26]]},"reference":[{"key":"R1-20250905","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11033-024-09708-x","article-title":"Advances in the development of biomarkers for brain damage and ischemia.","volume":"51","author":"Karimova","year":"2024","journal-title":"Mol Biol Rep"},{"key":"R2-20250905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40635-023-00587-3","article-title":"Mastering the brain in critical conditions: an update.","volume":"12","author":"Robba","year":"2024","journal-title":"Intensive Care Med Exp"},{"key":"R3-20250905","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.36922\/bh.2750","article-title":"Cerebral ischemia biomarkers: Their roles in early diagnosis and prognosis with potential clinical applications.","volume":"2","author":"Radenovic","year":"2024","journal-title":"Brain & Heart"},{"key":"R4-20250905","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.3390\/ijms25042372","article-title":"Innovative insights into traumatic brain injuries: biomarkers and new pharmacological targets int.","volume":"25","author":"Silvestro","year":"2024","journal-title":"J Mol Sci"},{"key":"R5-20250905","first-page":"1247","article-title":"Current trends in stroke biomarkers: the prognostic role of S100B and GFAP.","volume":"14","author":"Anogianakis","year":"2024","journal-title":"Life (Basel, Switzerland)"},{"key":"R6-20250905","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.bas.2023.102735","article-title":"Blood biomarkers for traumatic brain injury: a narrative review of current evidence.","volume":"4","author":"Hossain","year":"2023","journal-title":"Brain Spine"},{"key":"R7-20250905","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jamaneurol.2016.0039","article-title":"Time course and diagnostic accuracy of glial and neuronal blood biomarkers GFAP and UCH-L1 in a large cohort of trauma patients with and without mild traumatic brain injury.","volume":"73","author":"Papa","year":"2016","journal-title":"JAMA Neurol"},{"key":"R8-20250905","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol"},{"key":"R9-20250905","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1089\/neu.2013.2883","article-title":"GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.","volume":"30","author":"Okonkwo","year":"2013","journal-title":"J Neurotrauma"},{"key":"R10-20250905","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1089\/neu.2020.7140","article-title":"Point-of-care platform blood biomarker testing of glial fibrillary acidic protein versus S100 calcium-binding protein B for prediction of traumatic brain injuries: a transforming research and clinical knowledge in traumatic brain injury study.","volume":"37","author":"Okonkwo","year":"2020","journal-title":"J Neurotrauma"},{"key":"R11-20250905","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/neur.2020.0037","article-title":"Comparison of GFAP and UCH-L1 measurements from two prototype assays: the Abbott i-STAT and ARCHITECT assays.","volume":"2","author":"Korley","year":"2021","journal-title":"Neurotrauma Rep"},{"key":"R12-20250905","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/neu.2013.3040","article-title":"Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein.","volume":"31","author":"Diaz-Arrastia","year":"2014","journal-title":"J Neurotrauma"},{"key":"R13-20250905","first-page":"1","article-title":"Early GFAP and UCH-L1 point-of-care biomarker measurements for the prediction of traumatic brain injury and progression in patients with polytrauma and hemorrhagic shock.","volume":"May","author":"Sperry","year":"2024","journal-title":"J Neurosurg"},{"key":"R14-20250905","doi-asserted-by":"crossref","first-page":"e2431115","DOI":"10.1001\/jamanetworkopen.2024.31115","article-title":"Diagnostic performance of GFAP, UCH-L1, and MAP-2 within 30 and 60 minutes of traumatic brain injury.","volume":"7","author":"Papa","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R15-20250905","doi-asserted-by":"crossref","first-page":"104173","DOI":"10.1016\/j.bas.2024.104173","article-title":"Diagnostic and prognostic performance of urine ubiquitin carboxy-terminal hydrolase L1 across multiple acute brain injury types \u2013 a longitudinal prospective cohort study.","volume":"5","author":"Hellstr\u00f6m","year":"2024","journal-title":"Brain Spine"},{"key":"R16-20250905","doi-asserted-by":"crossref","first-page":"1470718","DOI":"10.3389\/fneur.2024.1470718","article-title":"Serum glial fibrillary acidic protein in acute stroke: feasibility to determine stroke-type, timeline and tissue-impact.","volume":"15","author":"Paul","year":"2024","journal-title":"Front Neurol"},{"key":"R17-20250905","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s41983-024-00829-5","article-title":"The role of blood protein biomarkers in acute ischemic stroke prognosis.","volume":"60","author":"Sabbah","year":"2024","journal-title":"Egypt J Neurol Psychiatry Neurosurg"},{"key":"R18-20250905","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2174\/0929867321666131218093327","article-title":"Neuritin, a neurotrophic factor in nervous system physiology.","volume":"21","author":"Zhou","year":"2014","journal-title":"Curr Med Chem"},{"key":"R19-20250905","doi-asserted-by":"crossref","first-page":"105407","DOI":"10.1016\/j.nbd.2021.105407","article-title":"Neuritin improves the neurological functional recovery after experimental intracerebral hemorrhage in mice.","volume":"156","author":"Lu","year":"2021","journal-title":"Neurobiol Dis"},{"key":"R20-20250905","doi-asserted-by":"crossref","first-page":"107391","DOI":"10.1016\/j.jstrokecerebrovasdis.2023.107391","article-title":"Neuritin has a neuroprotective role in the rat model of acute ischemia stroke by inhibiting neuronal apoptosis and NLRP3 inflammasome.","volume":"32","author":"Xu","year":"2023","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R21-20250905","doi-asserted-by":"crossref","first-page":"148909","DOI":"10.1016\/j.brainres.2024.148909","article-title":"Neuritin promotes autophagic flux by inhibiting the cGAS-STING pathway to alleviate brain injury after subarachnoid haemorrhage.","volume":"1836","author":"Zhang","year":"2024","journal-title":"Brain Res"},{"key":"R22-20250905","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/00207454.2017.1337013","article-title":"Neuritin attenuates early brain injury in rats after experimental subarachnoid hemorrhage.","volume":"127","author":"Zhang","year":"2017","journal-title":"Int J Neurosci"},{"key":"R23-20250905","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1111\/jcmm.15627","article-title":"Exogenous neuritin treatment improves survivability and functions of Schwann cells with improved outgrowth of neurons in rat diabetic neuropathy.","volume":"24","author":"Xi","year":"2020","journal-title":"J Cell Mol Med"},{"key":"R24-20250905","doi-asserted-by":"crossref","first-page":"1490023","DOI":"10.3389\/fneur.2024.1490023","article-title":"Serum neuritin as a predictive biomarker of early neurological deterioration and poor prognosis after spontaneous intracerebral hemorrhage: a prospective cohort study.","volume":"15","author":"Xu","year":"2025","journal-title":"Front Neurol"},{"key":"R25-20250905","doi-asserted-by":"crossref","first-page":"e16581","DOI":"10.1111\/ene.16581","article-title":"Prognostic serum biomarkers of synaptic, neuronal and glial injury in patients with acute ischemic stroke of the anterior circulation.","volume":"32","author":"Barba","year":"2025","journal-title":"Eur J Neurol"},{"key":"R26-20250905","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-024-02185-1","article-title":"Soluble urokinase-type plasminogen activator receptor and inflammatory biomarker response with prognostic significance after acute neuronal injury a prospective cohort study.","author":"Sajanti","year":"2024","journal-title":"Inflammation"},{"key":"R27-20250905","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neubiorev.2021.08.029","article-title":"The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury.","volume":"130","author":"Huibregtse","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"R28-20250905","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/neurolint17040055","article-title":"The relationship between clinical features of ischemic stroke and mirna expression in stroke patients: a systematic review.","volume":"17","author":"Prus","year":"2025","journal-title":"Neurol Int"},{"key":"R29-20250905","doi-asserted-by":"crossref","first-page":"18415","DOI":"10.1038\/s41598-023-45719-7","article-title":"Investigating microRNAs as biomarkers in disorders of consciousness: a longitudinal multicenter study.","volume":"13","author":"Musso","year":"2023","journal-title":"Sci Rep"},{"key":"R30-20250905","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.3390\/jcm13175065","article-title":"A pilot study of saliva microrna signatures in children with moderate-to-severe traumatic brain injury.","volume":"13","author":"Ciancaglini","year":"2024","journal-title":"J Clin Med"},{"key":"R31-20250905","doi-asserted-by":"crossref","first-page":"22539","DOI":"10.1038\/s41598-024-73579-2","article-title":"MiRNA expression profiling reveals a potential role of microRNA-148b-3p in cerebral vasospasm in subarachnoid hemorrhage.","volume":"14","author":"Ryu","year":"2024","journal-title":"Sci Rep"},{"key":"R32-20250905","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/ijms25052766","article-title":"The relevance of reperfusion stroke therapy for mir-9-3p and mir-9-5p expression in acute stroke-a preliminary study.","volume":"25","author":"Gendosz de Carrillo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R33-20250905","doi-asserted-by":"crossref","first-page":"123169","DOI":"10.1016\/j.jns.2024.123169","article-title":"Brain plasticity and neuroinflammatory protein biomarkers with circulating microRNAs as predictors of acute brain injury outcome \u2013 a prospective cohort study.","volume":"464","author":"Sajanti","year":"2024","journal-title":"J Neurol Sci"},{"key":"R34-20250905","doi-asserted-by":"crossref","first-page":"e1000145","DOI":"10.1371\/journal.pmed.1000145","article-title":"Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6.","volume":"6","author":"Whiteley","year":"2009","journal-title":"PLoS Med"},{"key":"R35-20250905","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.3390\/ijms17121967","article-title":"Update on inflammatory biomarkers and treatments in ischemic stroke.","volume":"17","author":"Bonaventura","year":"2016","journal-title":"Int J Mol Sci"},{"key":"R36-20250905","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11910-023-01282-2","article-title":"Neuroinflammation in acute ischemic and hemorrhagic stroke.","volume":"23","author":"Alsbrook","year":"2023","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R37-20250905","doi-asserted-by":"crossref","first-page":"110332","DOI":"10.1016\/j.intimp.2023.110332","article-title":"Neuroinflammation and peripheral immunity: focus on ischemic stroke.","volume":"120","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R38-20250905","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/neurintsurg-2021-017334","article-title":"A lower admission level of interleukin-6 is associated with first-pass effect in ischemic stroke patients.","volume":"14","author":"Mechtouff","year":"2022","journal-title":"J Neurointerv Surg"},{"key":"R39-20250905","doi-asserted-by":"crossref","first-page":"1488317","DOI":"10.3389\/fimmu.2024.1488317","article-title":"Associations of NETs with inflammatory risk and clinical predictive value in large artery atherosclerosis stroke: a prospective cohort study.","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"R40-20250905","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0271678X241276951","article-title":"A plasma lipid signature in acute human traumatic brain injury: link with neuronal injury and inflammation markers.","volume":"45","author":"Nessel","year":"2024","journal-title":"J Cereb Blood Flow Metab"},{"key":"R41-20250905","doi-asserted-by":"crossref","first-page":"1484742","DOI":"10.3389\/fneur.2024.1484742","article-title":"Changes in serum concentration of perioperative inflammatory cytokines following the timing of surgery among mild-moderate traumatic brain injury patients and factors associated.","volume":"15","author":"Lekuya","year":"2024","journal-title":"Front Neurol"},{"key":"R42-20250905","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12974-024-03236-y","article-title":"Cerebrospinal fluid markers of neuroinflammation and coagulation in severe cerebral edema and chronic hydrocephalus after subarachnoid hemorrhage: a prospective study.","volume":"21","author":"Fang","year":"2024","journal-title":"J Neuroinflammation"},{"key":"R43-20250905","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1038\/s41598-025-87062-z","article-title":"Relationship between growth differentiation factor 15 and functional prognosis and severity in traumatic brain injury.","volume":"15","author":"Ito","year":"2025","journal-title":"Sci Rep"},{"key":"R44-20250905","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1474-4422(22)00256-3","article-title":"Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.","volume":"21","author":"Korley","year":"2022","journal-title":"Lancet Neurol"}],"container-title":["Current Opinion in Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T12:02:59Z","timestamp":1757073779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ACO.0000000000001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,26]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aco.0000000000001532","relation":{},"ISSN":["0952-7907","1473-6500"],"issn-type":[{"value":"0952-7907","type":"print"},{"value":"1473-6500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,26]]}}}